Akamatsu, H., Negoro, K., Ueda, R., Nakaguchi, K., Harutani, Y., Takase, E., Furuta, K., Murakami, Y., Murakami, E., Hayata, A., Wan, K., Shimokawa, T., Kanai, K., Yamamoto, N. (2025). A phase 2 study of CBDCA + PEM + pembrolizumab in elderly (≥75 yrs) patients with advanced non-Sq, NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e20616